摘要
目的观察和评价多索茶碱治疗肺癌术后并发支气管哮喘的临床疗效及护理。方法将87例肺癌术后并发支气管哮喘患者随机分为多索茶碱治疗组(A组)和氨茶碱治疗对照组(B组)。观察和对比两组患者治疗后的疗效、血气变化及毒副反应。结果 A组临床症状及血气指标改善的总有效率高于B组,且毒副反应发生率较低,两组比较差异有统计学意义(P<0.05)。结论多索茶碱是一种安全有效的治疗肺癌术后并发支气管哮喘的药物,值得临床推广使用。
Objective To investigate and evaluate the clinical effect of doxofylline and the nursing measures to bronchail asthma following lung cancer surgery.Methods eighty seven cases of bronchial asthma patients following lung cancer surgery were randomly divided into the doxofylline treatment group Group A and the aminophylline treatment group（Group B）.Clinical symptoms,blood gas index and the incidence rate of adverse reaction were observed.Results The total clinical effective rate of the doxofylline treatment group was higher than that of the aminophylline treatment group,and the incidence rate of the toxicities was lower.The difference between two groups was significant（P0.05）.Conclusion doxofylline is a safe and effective drug for bronchail asthma following lung cancer surgery.
出处
《肿瘤基础与临床》
2010年第3期259-260,共2页
journal of basic and clinical oncology
关键词
多索茶碱
肺癌
手术
支气管哮喘
Doxofylline
lung cancer
surgery
bronchial asthma
